Dr James Wood is an applied mathematician with interests across a broad range from evolutionary and immunological processes to cost-effectivenesss evaluations for disease interventions. He completed his honours degree and PhD at the University of Queensland (both in mathematical physics). His primary application area is vaccine preventable diseases but he also has interests in tuberculosis and resistance in bacterial infections more broadly.
He has published over 40 papers in international journals, focussing on the impact and cost-effectiveness of vaccines on epidemiology, along with research related disease elimination and parameter estimation (particularly for measles). He was previously quite involved in research in emerging infections (particularly planning for influenza pandemics). His current interests are particularly in integrating genetic and immunologic elements into epidemiological models to account for trends in pathogen resistance and declining population immunity, with applications to infections such as pertussis, gonorrhea, tuberculosis and measles.
Current funded projects:
James is a CI on a 2015- funded NHMRC Centre for Research Excellence (Prism^2) in infectious disease modelling headed by A/Prof Jodie McVernon of University of Melbourne. Look out for postdoc announcements and workshops connected with this centre.
James is a CI on 2 current Australian grants (NHRMC/ARC) led by Dr Tony Newall of UNSW looking at economic evaluation of pneumococcal and rotavirus vaccines.
James is on a CI on 2 major NHMRC funded trials of Tuberculosis screening interventions in Vietnam led by Professor Guy Marks. He is also an AI on the Tuberculosis CRE http://tbcre.org.au/
Potential research students: Students with a strong quantitative background and interest in population dynamics of infectious diseases should contact me by email (email@example.com).
Current student projects (with Dr David Regan of the Kirby Insitute UNSW)
Using mathematical modelling to evaluate antimicrobial stewardship strategies for minimising the impact of multi-drug resistant gonorrhoea in Australia (PhD)